Biotechnology

CMAB Biopharma Appoints Mr. Ye Shi as Head of Quality

SUZHOU, China, April 3, 2020 /PRNewswire/ -- CMAB Biopharma (Suzhou) Inc. ("CMAB"), a dedicated biologics contract manufacturing and development organization (CDMO), today announced the appointment of Mr. Ye Shi as the Head of Quality. He will be responsible for the overall management of the qual...

2020-04-03 09:12 1416

Atomo secures significant European sales agreement for rapid COVID-19 tests as $30m Initial Public Offer closes oversubscribed

SYDNEY, April 3, 2020 /PRNewswire/ -- Australian rapid blood test company Atomo Diagnostics Limited today said it had entered into a binding supply agreement with French diagnostics company, NG Biotech, SAS (NG Biotech), for the supply of Atomo's integrated blood test devices to NG Biotech to use...

2020-04-02 21:01 1035

Ansun Biopharma Announces Positive Results from Investigator-Initiated Trial of Novel COVID-19 Treatment

Treatment with DAS181, a clinical-stage recombinant biologic, reduced or eliminated the need for supplemental oxygen, and improved key patient vital signs SAN DIEGO, April 2, 2020 /PRNewswire/ -- Ansun Biopharma, Inc., a clinical stage biopharmaceutical company, today announced preliminary data ...

2020-04-02 19:00 819

Neteera, the Global Leader in Contact-free Vital Signs Monitoring, Launches Contactless Vital Signs Sensing System for COVID-19 Early Screening and Home Care

JERUSALEM, March 31, 2020 /PRNewswire/ -- As the world grapples with the current COVID-19 (Coronavirus) pandemic, the spotlight has been thrown on the interface between those afflicted by the virus, and the infrastructure delivering essential treatment to those in urgent need. It is precisely at...

2020-04-01 13:37 687

GenScript Biotech Reports 2019 Financial Results and Provides Business Update

NANJING, China, April 1, 2020 /PRNewswire/ -- GenScript Biotech Corp. (Stock Code: 1548.HK), a leading global biotechnology company, yesterday reported full year 2019 financial results and provided a corporate update. In 2019, overall revenue of the Group was approximatelyUS$273.4 million, repres...

2020-04-01 08:36 4949

Viva Biotech Announced 2019 Annual Results

Financial Highlights For the year ended December 31, 2019 * Revenue amounted to approximately RMB323.1 million, representing a significant YOY increase of 53.9% from approximatelyRMB210.0 million in the same period last year. * Gross profit amounted to approximately RMB155.9 million, represe...

2020-03-31 11:45 1463

Innovent Announces Financial Results for Full Year Ended December 31, 2019 and Corporate Progress

SUZHOU, China, March 30, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent" or "the Company") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality innovative medicines for the treatment of oncology, autoimmune, metabolic and oth...

2020-03-31 00:08 1429

Tiger Asia Intelligence Initiates Coverage on AnPac Bio, Ltd

NEW YORK, March 30, 2020 /PRNewswire/ -- Tiger Asia Intelligence has announced it has initiated coverage on AnPac Bio, Ltd (NASDAQ: ANPC). The full report can be found here:  AnPac Report Key Report Highlights: AnPac Bio-Medical Science Co., Ltd. (NASDAQ: ANPC) is a biotechnology company with op...

2020-03-30 20:30 1095

Fapon Donation Reaches 3 Million PCR Test Components Globally and Welcomes More Participation

DONGGUAN, China, March 30, 2020 /PRNewswire/ -- Fapon Biotech Inc . (Fapon), a global leading IVD raw materials and one-stop solutions company offering products and technologies to enable the rapid development and pro...

2020-03-30 20:15 632

Nano Retina Announces Preliminary Results for First-in-Human Implantation of Its NR600 Artificial Retina Device

The device is designed to restore vision to persons blinded by age-related macular degeneration and retinitis pigmentosa First two patients to receive the device in March 2020 report visual effect HERZLIYA, Israel, March 30, 2020 /PRNewswire/ -- Nano Retina Ltd., developer of the NR600, an artif...

2020-03-30 08:00 736

Foresee Pharmaceuticals and Accord Healthcare Announce MAA Submission for Camcevi(R) 42mg

TAIPEI, March 27, 2020 /PRNewswire/ -- Foresee Pharmaceuticals Co., Ltd. (6576.TWO) ("Foresee") and Accord Healthcare announced today that a Marketing Authorization Application (MAA) forCamcevi® 42mg (FP-001 LMIS 50mg), a ready-to-use 6-month depot formulation of leuprolide mesylate, has been su...

2020-03-27 19:53 1044

C(2) PHARMA Opens Government and Research Access to Safety Stock of DIGOXIN API for Use in Potential COVID-19 Combination Treatment

LUXEMBOURG, March 27, 2020 /PRNewswire/ -- C2 PHARMA s.a.r.l. (C2P), a Luxembourg-based phytochemical and chemical pharmaceutical manufacturing and distribution group, is announcing that they will open access to safety stocks of the active pharmaceutical ingredient (API), Digoxin. In early March,...

2020-03-27 07:33 1277

European and U.S. Antitrust Authorities Clear Acquisition of Select Danaher Life Science Businesses by Sartorius

GOTTINGEN, Germany, March 20, 2020 /PRNewswire/ -- On March 18 and March 19, 2020 respectively, the European Commission and the U.S. Federal Trade Commission cleared the proposed acquisition of select Danaher businesses by Sartorius. Both approvals are an important milestone for the transaction ...

2020-03-20 20:36 8013

AGC Biologics to Participate in Virtual BIO-Europe Spring

AGC Biologics Sponsors 14th Annual BIO-Europe Spring Conference SEATTLE, March 20, 2020 /PRNewswire/ -- AGC Biologics is pleased to be a gold sponsor of BIO-Europe Spring,Europe's largest springtime biotech partnering event. In order to ensure the health of all those participating, the event will...

2020-03-20 03:43 1553

DCAT Week Cancelled, AGC Biologics to Meet Virtually with Industry Leaders

AGC Biologics fosters strong customer partnerships by conducting virtual meetings SEATTLE, March 20, 2020 /PRNewswire/ -- Due to the recent cancellation of DCAT Week,AGC Biologics will be meeting virtually with industry leaders who planned to attend the event. As a Contract Development and Manuf...

2020-03-20 02:44 1538

Zai Lab Announces Financial Results for Full Year Ended December 31, 2019 and Corporate Updates

SHANGHAI and SAN FRANCISCO, March 19, 2020 /PRNewswire/ -- Zai Lab Limited (NASDAQ: ZLAB), aChina and U.S.-based innovative commercial stage biopharmaceutical company, today announced financial results for the twelve months endedDecember 31, 2019 and corporate updates. "Coinciding with the celeb...

2020-03-20 00:21 1868

Golden Meditech's Associate, Cellenkos, Focuses on the Development of Cell-theray for Treatment of COVID-19 Mediated Acute Respiratory Distress Syndrome (CoV-ARDS)

HONG KONG, March 18, 2020 /PRNewswire/ -- Golden Meditech Holdings Limited (SEHK stock code: 00801) ("Golden Meditech"), a leading integrated healthcare enterprise inChina, announced that its associate, Cellenkos, Inc. ("Cellenkos") has submitted a clinical development proposal to the Biomedical ...

2020-03-18 18:16 1916

Beauty Tourism is Causing A Rising Need For Surgical Revisions

SINGAPORE, March 17, 2020 /PRNewswire/ -- Dr. Ivan Puah, Medical Director of Amaris B. Clinic, has noticed a rise in failed results, such as botched procedures in liposuction and gynecomastia surgery, among patients who had their cosmetic procedures done overseas. Dr. Puah, accredited by the Mini...

2020-03-17 09:30 1072

KUKA Lauded with Frost & Sullivan's Company of the Year Award for Demonstrating Excellence in Growth, Innovation, and Leadership in the Medical Robotics Business

Its extensive product line ranging from small up to heavy payload robots allows it to support customised applications LONDON, March 12, 2020 /PRNewswire/ -- Based on its recent analysis of the global medical robotics market, Frost & Sullivan recognisesKUKA with the 2020 Global Company of the Yea...

2020-03-12 20:00 1579

Bactiguard Launches Product That Protects Against Coronavirus

STOCKHOLM, March 12, 2020 /PRNewswire/ -- Bactiguard launches HYDROCYN aqua®, a water-based product that has been proven to have a powerful effect on killing previous variants of coronavirus within 15-30 seconds. Previous experience shows that the proven effect can be transferred to new variants ...

2020-03-12 15:49 1317
12345 ... 59